BNP Paribas Financial Markets
IRLA

BNP Paribas Financial Markets’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

BNP Paribas Financial Markets’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– -$1 – 6107
2026
Q1 		– Hold
0
– – – 5801
2025
Q4 		– Hold
0
– – – 5661
2025
Q3 		– Hold
0
– – – 5514
2025
Q2 		– Hold
0
– – – 5403
2024
Q3 		– Hold
0
– -$18 – 4221
2024
Q2 		– Hold
0
– – – 4010
2024
Q1 		– Hold
0
– – – 3997
2023
Q4 		– Hold
0
– – – 3977
2023
Q3 		– Hold
0
– – – 3863
2023
Q2 		– Sell
-3
Closed -$934 – 3862
2023
Q1 		$1.01K Sell
3
-3
-50% -$587 ﹤0.01% 3686
2022
Q4 		$771 Sell
6
-1,030
-99% -$172K ﹤0.01% 3834
2022
Q3 		$276K Sell
1,036
-392
-27% -$149K ﹤0.01% 3336
2022
Q2 		$634K Sell
1,428
-216
-13% -$153K ﹤0.01% 2523
2022
Q1 		$2.04M Buy
1,644
+746
+83% +$1.02M ﹤0.01% 1798
2021
Q4 		$2.27M Buy
898
+880
+4,889% +$5.37M ﹤0.01% 1915
2021
Q3 		$329K Buy
18
+14
+350% +$223K ﹤0.01% 2901
2021
Q2 		$39.1K Sell
4
-12
-75% -$101K ﹤0.01% 3353
2021
Q1 		$114K Sell
16
-19
-54% -$137K ﹤0.01% 3296
2020
Q4 		$194K Buy
35
+16
+84% +$142K ﹤0.01% 2898
2020
Q3 		$187K Buy
19
+16
+533% +$146K ﹤0.01% 2790
2020
Q2 		$31.4K Sell
3
-14
-82% -$128K ﹤0.01% 3220
2020
Q1 		$158K Buy
17
+9
+113% +$88.8K ﹤0.01% 2972
2019
Q4 		$87.1K Buy
8
+6
+300% +$36.2K ﹤0.01% 3353
2019
Q3 		$9.1K Buy
+2
New +$12.3K ﹤0.01% 4169
2019
Q2 		– Hold
0
– – – 4394

Other funds holding IRLA

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's IRLA Position: Q2 2026 in Review

BNP Paribas Financial Markets held its IRulya Therapeutics Inc. Common Stock (IRLA) position steady in Q2 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6107.

BNP Paribas Financial Markets first reported a position in IRLA in Q3 2019 and has held it in 15 quarters since. The position peaked at $2.27M in Q4 2021. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

  • BNP Paribas Financial Markets held 0 shares of IRulya Therapeutics Inc. Common Stock worth $0 as of Q2 2026.
  • BNP Paribas Financial Markets left its IRulya Therapeutics Inc. Common Stock share count unchanged in Q2 2026.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #6107 holding.
  • BNP Paribas Financial Markets first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2019 and has held it in 15 quarters since.
  • BNP Paribas Financial Markets's IRulya Therapeutics Inc. Common Stock position peaked at $2.27M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.